Pomalidomide-Dexamethasone in the Management of Heavily Pretreated Multiple Myeloma

被引：0
|
作者：
Cerchione, Claudio [1 ]
Martinelli, Giovanni [2 ]
Nappi, Davide [3 ]
Pareto, Anna Emanuele [3 ]
Di Perna, Maria [3 ]
Ronconi, Sonia [4 ]
Pane, Fabrizio [3 ]
Catalano, Lucio [5 ]
机构：
[1] IRCCS, IRST, Meldola, FC, Italy
[2] IRCCS, Ist Sci Romagnolo Studio & Cura Tumori IRST, Hematol Unit, Meldola, FC, Italy
[3] AOU Federico II, Naples, Italy
[4] European Myeloma Network Italy, GIMEMA, Meldola, Italy
[5] AOU Federico II, GIMEMA, Naples, Italy
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2019年 / 19卷 / 10期
关键词：
Heavily pretreated; Pomalidomide; Real-World Data;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SP-309
引用
收藏
页码：E359 / E359
页数：1
相关论文
共 50 条
  • [1] Pomalidomide-Dexamethasone in the Management of Heavily Pretreated Multiple Myeloma
    Cerchione, Claudio
    Nappi, Davide
    Pareto, Anna Emanuele
    Migliaccio, Ilaria
    Zacheo, Irene
    Di Perna, Maria
    Peluso, Ilaria
    Ferrara, Katia
    Pane, Fabrizio
    Catalano, Lucio
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S256 - S256
  • [2] POMALIDOMIDE-DEXAMETHASONE IN THE MANAGEMENT OF HEAVILY PRETREATED MULTIPLE MYELOMA
    Cerchione, C.
    Nappi, D.
    Pareto, A. E.
    Migliaccio, I
    Zacheo, I
    Di Perna, M.
    Peluso, I
    Ferrara, K.
    Pane, F.
    Catalano, L.
    HAEMATOLOGICA, 2018, 103 : 39 - 39
  • [3] POMALIDOMIDE-DEXAMETHASONE IN THE MANAGEMENT OF HEAVILY PRETREATED MULTIPLE MYELOMA
    Cerchione, C.
    Catalano, L.
    Nappi, D.
    Pareto, A. E.
    Musuraca, G.
    Lucchesi, A.
    Ronconi, S.
    Ceccolini, M.
    Cangini, D.
    Giannini, M. B.
    Di Battista, V.
    Simonetti, G.
    Ferrari, A.
    Bochicchio, M. T.
    di Rora, A. Ghelli Luserna
    Ghetti, M.
    Napolitano, R.
    Fontana, M. C.
    Padella, A.
    Pane, F.
    Martinelli, G.
    HAEMATOLOGICA, 2020, 105 : S105 - S105
  • [4] Pomalidomide-Dexamethasone in the Management of Heavily Pretreated Multiple Myeloma
    Cerchione, Claudio
    Catalano, Lucio
    Nappi, Davide
    Pareto, Emanuele
    Pane, Fabrizio
    Martinelli, Giovanni
    BLOOD, 2021, 138
  • [5] Pomalidomide-Dexamethasone in the Management of Heavily Pretreated Multiple Myeloma
    Nappi, Davide
    Catalano, Lucio
    Pane, Fabrizio
    Martinelli, Giovanni
    Cerchione, Claudio
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S442 - S442
  • [6] Pomalidomide-Dexamethasone in the Management of Heavily Pretreated Multiple Myeloma
    Cerchione, Claudio
    Nappi, Davide
    Pareto, Anna Emanuele
    Pane, Fabrizio
    Catalano, Lucio
    BLOOD, 2018, 132
  • [7] POMALIDOMIDE-DEXAMETHASONE IN THE MANAGEMENT OF HEAVILY PRETREATED MULTIPLE MYELOMA
    Cerchione, C.
    Nappi, D.
    Pareto, A. E.
    Migliaccio, I.
    Zacheo, I.
    Di Perna, M.
    Peluso, I.
    Ferrara, K.
    Pane, F.
    Catalano, L.
    HAEMATOLOGICA, 2018, 103 : S116 - S116
  • [8] POMALIDOMIDE-DEXAMETHASONE IN THE MANAGEMENT OF HEAVILY PRETREATED MULTIPLE MYELOMA
    Cerchione, C.
    Nappi, D.
    Pareto, A. E.
    Migliaccio, I.
    Zacheo, I.
    Di Perna, M.
    Peluso, I.
    Ferrara, K.
    Pane, F.
    Catalano, L.
    HAEMATOLOGICA, 2017, 102 : 139 - 140
  • [9] Pomalidomide-Dexamethasone in the Management of Heavily Pretreated Multiple Myeloma
    Cerchione, Claudio
    Martinelli, Giovanni
    Catalano, Lucio
    AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 : S5 - S5
  • [10] Pomalidomide-Dexamethasone in the Management of Heavily Pretreated Multiple Myeloma
    Cerchione, Claudio
    Catalano, Lucio
    Nappi, Davide
    Pareto, Anna Emanuele
    Musuraca, Gerardo
    Lucchesi, Alessandro
    Ronconi, Sonia
    Ceccolini, Michela
    Cangini, Delia
    Giannini, Maria Benedetta
    Di Battista, Valeria
    Simonetti, Giorgia
    Di Rora, Andrea Ghelli Luserna
    Pane, Fabrizio
    Martinelli, Giovanni
    BLOOD, 2020, 136
12345